Advertisements

Acetylcystein Hexal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Acetylcystein Hexal

Quick Facts

Property Description
Active ingredient Acetylcysteine (N-Acetylcysteine, NAC)
Form Typically Effervescent Tablets (for oral solution)
Pharmacological class Mucolytic Agent, Expectorant
General purpose Thinning thick respiratory mucus
Origin Synthetic, Small Molecule, Prodrug

What Type of Medicine is Acetylcystein Hexal (Composition and Class)?

Acetylcystein Hexal is a medication containing the single active substance Acetylcysteine (N-Acetylcysteine or NAC), which is the N-acetyl derivative of the naturally occurring amino acid L-cysteine. It is classified as a mucolytic agent and an expectorant. This specific brand focuses on oral delivery methods for the active ingredient.

Mucolytic agents like Acetylcysteine work by changing the physical properties of mucus. The substance also functions as a prodrug that supplies the body with L-cysteine, a precursor for the body's internal antioxidant, glutathione.

What is the Primary Function and General Purpose of Acetylcysteine?

The purpose of Acetylcysteine is to modify and thin thick, viscous mucus and secretions in the respiratory tract, which often occur during respiratory congestion. It achieves this by breaking the disulfide bonds within the mucoproteins, thereby reducing the viscosity and adhesiveness of the mucus.

By transforming these secretions into a more liquid consistency, the medication facilitates expectoration (coughing up mucus) and helps clear the airways. The therapeutic intent is to support respiratory function and provide relief of chest congestion caused by mucus retention.

Forms and Administration Type (Effervescent Tablets and Solutions)

Acetylcystein Hexal is used via the oral route, often provided as effervescent tablets that are dissolved in water to create a solution for swallowing. The use of effervescent tablets is a primary characteristic of this product’s preparation. The active ingredient, Acetylcysteine, is produced in various dosage forms, including oral solutions and forms intended for inhalation via a nebulizer.

Regulatory References

  1. Acetylcysteine Solution, USP - DailyMed
  2. Acetylcysteine Oral Inhalation: MedlinePlus Drug Information
Advertisements

What side effects are possible with Acetylcystein Hexal?

Possible Side Effects and Safety Information

This section summarizes the adverse reactions and safety restrictions for Acetylcystein Hexal, as officially documented in governmental regulatory sources. The frequency of side effects is categorized based on standard medical conventions.

Documented Adverse Reactions

Frequency Category Examples of Documented Reactions
Uncommon (1 in 1,000 to 1 in 100) Hypersensitivity reactions (e.g., rash, pruritus), headache, tachycardia, nausea, vomiting, diarrhoea, abdominal pain, fever, hypotension.
Rare (1 in 10,000 to 1 in 1,000) Bronchospasm (difficulty breathing), dyspepsia.
Very Rare (Fewer than 1 in 10,000) Anaphylactic shock, severe skin reactions (e.g., Stevens-Johnson syndrome), haemorrhages (bleeding).

System-Organ Classes Affected

Reported adverse effects are categorized across multiple body systems, including Immune system, Nervous system, Gastrointestinal disorders, Respiratory, thoracic and mediastinal disorders, and Skin and subcutaneous tissue disorders.

Serious Adverse Reactions

Serious adverse reactions, though very rare, include anaphylactic shock and severe, sometimes life-threatening, skin reactions like Stevens-Johnson syndrome. If any signs of severe hypersensitivity or difficulty breathing occur, immediate medical attention is necessary.

Safety Restrictions and Special Populations

  • Contraindication: Acetylcystein Hexal is contraindicated in children under 2 years of age due to the risk of airway obstruction. It is also contraindicated for individuals with known hypersensitivity to acetylcysteine or any of the excipients.
  • Precautions: Caution and close supervision are required for patients with bronchial asthma, as there is a risk of bronchospasm. Caution is also advised for patients with a history of peptic ulcers.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of acetylcysteine is officially documented as primarily causing localized gastrointestinal effects due to mucosal irritation. These manifestations typically include nausea, vomiting, and diarrhoea. While the acute oral toxicity is characterized as low in regulatory documents, high-concentration exposures may lead to systemic signs such as stomatitis, drowsiness, and fever.

The official guidance mandates immediate emergency treatment if severe or life-threatening symptoms occur. This includes any instance where the individual has collapsed, had a seizure, is experiencing trouble breathing, or cannot be awakened. In any suspected overdose situation, the official instruction is to immediately call emergency services or the Poison Control helpline.

Management is strictly limited to symptomatic and supportive treatment, as regulatory documents confirm that no specific antidote for the acetylcysteine compound is known. Due to the medication’s effect on secretions, a key supportive measure described is ensuring the airway is maintained and, if necessary, utilizing mechanical suction to clear excessive liquefied bronchial secretions.

Advertisements

Therapeutic Uses of Acetylcystein Hexal

What Acetylcystein Hexal Treats: Main Uses and Benefits

The medication is commonly used in situations involving certain distressing symptoms linked to conditions such as acute respiratory infections or acute symptomatic episodes. Acetylcysteine is generally indicated as part of symptomatic management for patients with mucous secretions that are difficult to move, such as in chronic and acute bronchopulmonary disease. This is relevant for managing symptoms that create noticeable physiological strain, applied when chest congestion is heavy and symptoms related to physical discomfort are present.

It generally provides support that helps ease the overall symptom burden by assisting in the movement and clearance of accumulated phlegm. It is also applied across therapeutic domains involving chronic mucus hypersecretion, generally used as part of symptomatic management in conditions like Chronic Obstructive Pulmonary Disease (COPD) and cystic fibrosis. In these scenarios, the medication may assist with maintaining a sense of stability when symptoms are more noticeable, and supports the patient during difficult episodes by easing the distress linked to secretions.


Quick Fact: Support for Symptoms that Interfere with Daily Functioning

Use Category Common Conditions Core Benefit Focus
Acute Acute respiratory infections, symptomatic episodes Helps with symptoms related to physical discomfort
Chronic COPD, Cystic Fibrosis (adjunct use) Contributes to improved comfort during periods of heightened symptoms

Regulatory References

  1. US National Library of Medicine DailyMed
Advertisements

Eligibility and Restrictions for Use

Eligibility and Contraindications for Acetylcystein Hexal

Official regulatory information defines clear population rules for the use of Acetylcystein Hexal, an oral mucolytic containing Acetylcysteine.

Absolute Prohibitions (Contraindications)

The medicine must not be used in the following populations, as stated in regulatory labels:

  • Children under 2 years of age (due to the risk of airway obstruction).
  • Individuals with known hypersensitivity to the active substance (Acetylcysteine) or any excipients.
  • Patients with phenylketonuria or fructose intolerance if the formulation contains specific corresponding excipients (e.g., aspartame or sorbitol).

Age-Related Eligibility

Age Group Eligibility Status
Under 2 years Contraindicated
2–14 years Eligible for lower-strength formulations
Adolescents (14+) & Adults Eligible for all labeled strengths, including 600 mg

Conditional Use and Restrictions

Use requires close medical monitoring in patients with bronchial asthma (discontinuation required if bronchospasm occurs) and in those with a history of peptic ulcer. Furthermore, the medicine is not recommended during pregnancy or breastfeeding unless strictly assessed and determined necessary by a medical professional due to insufficient safety data.

Advertisements

What should I know about interactions with other medicines?

Acetylcystein Hexal Interactions with other medicines and products

The official regulatory profile for Acetylcysteine documents specific interaction patterns concerning co-administered medicinal products and chemical incompatibilities. These interactions are classified primarily as pharmacodynamic interference or chemical inactivation, rather than metabolic or transporter-based interactions.


Documented Drug–Drug Interactions

Co-administration with antitussive agents (cough suppressants) is restricted. This limitation is due to the resulting pharmacodynamic interference where the suppression of the cough reflex can lead to the stagnation and accumulation of bronchial secretions.

A pharmacodynamic potentiation is documented with Nitroglycerin (Glyceryl Trinitrate). The co-administration may cause an increase in the vasodilatory effect of Nitroglycerin, which can result in a reported risk of significant hypotension and the subsequent onset of headache. Additionally, concomitant use may lead to sub-therapeutic plasma levels of Carbamazepine.


Administration and Chemical Constraints

The administration of oral antibiotics, including certain Cephalosporins and Tetracyclines, requires a mandatory separation of at least two hours from Acetylcysteine. This timing rule is necessary due to the documented inactivation of the antibiotic when the substances are mixed.

Interaction with Activated Charcoal is noted; this substance may officially result in reduced therapeutic effectiveness of Acetylcysteine through an in vitro adsorption mechanism. Finally, the Acetylcysteine solution must not be mixed with any other medicinal products or with solutions containing metal ions. This is a chemical incompatibility constraint derived from the nature of the active substance.

Advertisements

Mechanism of Action

The action of Acetylcysteine is defined by a dual mechanistic approach involving direct chemical alteration of secretions and the modulation of cellular antioxidant capacity.

Direct Chemical Mucolysis: Cleaving Mucin Cross-Links

The primary function involves Acetylcysteine acting as a chemical reductant that directly targets the structural integrity of highly viscous secretions in the airways. It accomplishes this by donating a free sulfhydryl group (SH) that breaks the stabilizing disulfide bonds (S-S) within the mucoprotein network. This molecular action causes the secretions to undergo depolymerization, leading to a sharp reduction in their viscosity and adhesiveness. The resulting reduction in viscosity and adhesiveness allows for increased effectiveness of mucociliary transport.

Indirect Antioxidant Support: Glutathione Precursor

A secondary mechanism involves Acetylcysteine acting as a prodrug that supplies the necessary building block, L-Cysteine, for the synthesis of the endogenous antioxidant, Glutathione (GSH). By supporting the replenishment of intracellular GSH stores, the mechanism bolsters the cellular capacity to neutralize Reactive Oxygen Species (ROS) and mitigate oxidative stress. This function results in enhanced cytoprotection for respiratory epithelial cells against insults mediated by oxidative species.

Advertisements

Dosage and Administration Information

Acetylcysteine, the active substance in Acetylcystein Hexal, is administered according to standardized regimens. The primary route of delivery for the Effervescent Tablet form is oral, requiring the tablet to be fully dissolved in water immediately prior to ingestion. The resulting solution is typically directed to be taken after meals to support standardized use and should not be mixed with any other medicine during preparation.

The standardized dosing schedule for adults and adolescents over 14 years is 600 mg once daily, although some formulations may necessitate administration up to three times per day. The use of the oral form for acute episodes should generally not exceed 14 days without further assessment, defining a specific temporal constraint on administration. If a dose is missed, it is advised not to take a double dose to compensate, maintaining the original frequency pattern.

The medication is also administered by inhalation via nebulizer or by direct instillation into the respiratory tract, providing alternative routes for specialized contexts. For nebulization, a specific procedural condition exists: the use of a 10% or 20% solution often requires an aerosolized bronchodilator to be given 10 to 15 minutes before the Acetylcysteine administration. Furthermore, it is prohibited to use any mucolytic form in children under 2 years of age due to physiological constraints. The necessity of maintaining high fluid intake is also noted to support the product's function.

Advertisements

Recent Clinical Evidence

Acetylcystein Hexal: Recent Clinical Evidence

Clinical studies have primarily focused on the mucolytic action of acetylcysteine, which aims to reduce the thickness and stickiness of mucus to facilitate its removal from the airways. This use is well-established for managing conditions associated with excessive or thick respiratory secretions, such as chronic bronchitis.

Chronic Respiratory Disease

Research has explored the role of prolonged oral acetylcysteine use, especially at higher daily doses, in individuals with Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis. Findings from meta-analyses have documented instances where long-term administration may be associated with a reduced rate of disease exacerbations in certain patient groups.

However, other large-scale randomized controlled trials (RCTs) conducted in patients with mild-to-moderate COPD have not consistently demonstrated a significant impact on outcomes such as the annual rate of exacerbations or improvement in lung function measurements, including forced expiratory volume in one second (FEV1). These mixed results highlight ongoing investigation into the specific patient profile and dose that may show the most pronounced effect.


Additional Areas of Research

Beyond its mucolytic role, acetylcysteine is the standard treatment for acetaminophen (paracetamol) overdose, where it works by helping to restore levels of the antioxidant glutathione in the liver. This mechanism is key to neutralizing toxic metabolites and protecting liver cells.

Further research is ongoing into the molecule’s antioxidant and anti-inflammatory properties across a wide range of other conditions. These investigational areas include its potential effects in certain neurological and psychiatric disorders, as well as its possible role in reducing oxidative stress and inflammation in various acute conditions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Acetylcystein Hexal (FAQ)

Q: Is Acetylcystein Hexal the same as regular N-acetylcysteine (NAC)?

A: Acetylcystein Hexal is a specific brand name for a medication whose active ingredient is Acetylcysteine. This active substance is chemically identical to what is commonly referred to as N-acetylcysteine, or NAC. Therefore, the medication contains the same core compound found in other Acetylcysteine products.


Q: Can Acetylcystein Hexal make my cough worse before it gets better?

A: As a mucolytic agent, Acetylcysteine works by reducing the stickiness and thickness of the mucus in the airways. The official mechanism of action explains that the goal of this action is to facilitate the clearing of the airways. This process may sometimes result in a temporary change in the amount of mucus being expelled.


Q: Does Acetylcystein Hexal interact with common pain relievers like ibuprofen?

A: Official regulatory documents list specific interactions with certain classes of drugs, such as antibiotics and antitussives (cough suppressants). While common over-the-counter pain relievers are not generally named in these specific interaction lists, information regarding co-administered medications should be reviewed by a healthcare professional.


Q: Are there any common reasons people stop taking Acetylcystein Hexal?

A: Official product information emphasizes that the medicine must be discontinued immediately if a patient experiences specific serious adverse events. These include severe hypersensitivity reactions, such as anaphylactic shock, or a sudden difficulty breathing known as bronchospasm. These events, although rare, are considered serious and necessitate seeking professional medical evaluation.


Q: What happens if I miss a dose of Acetylcystein Hexal?

A: Regulatory instructions for this type of medication advise against taking a double dose to compensate for the one that was missed. The regulatory documents suggest maintaining the original frequency pattern.


Q: Are there any foods or drinks that should be avoided while taking Acetylcystein Hexal?

A: The official product information specifies that the effervescent tablet should be dissolved in water only. The resulting solution must not be mixed with any other medicine during preparation. While the medicine is typically directed to be taken after meals, there are no general dietary restrictions mentioned in the regulatory documents.


Q: Does Acetylcystein Hexal affect my ability to drive or operate machinery?

A: Official safety documents list potential side effects that could indirectly affect mental clarity and concentration, such as headache or occasional hypotension (low blood pressure). Because of these potential effects, it is generally advised that individuals observe their reaction to the medication before performing tasks that require concentration.


Q: Can Acetylcystein Hexal interact with birth control pills?

A: Official drug labels list specific drug-drug interactions with other compounds but generally do not indicate an interaction between Acetylcysteine and hormonal contraceptive pills. Specific concerns about co-administered medications may warrant review by a healthcare professional.


Q: What is the difference between the various strengths of Acetylcystein Hexal available?

A: The available strengths are designed to address different patient populations based on age. Standard dosing, such as the 600 mg option, is intended for adolescents over 14 years and adults. Lower-strength formulations are made available for the appropriate treatment of children between 2 and 14 years of age.


Q: Does Acetylcystein Hexal interact with commonly prescribed heart medications?

A: One documented interaction is with Nitroglycerin (Glyceryl Trinitrate), a medicine often used for heart conditions. When taken together, Acetylcysteine may enhance the vasodilatory effect, which can lead to a risk of low blood pressure (hypotension) and a resulting headache. Any potential interactions with heart medications should be reviewed with a healthcare provider.


Q: Why does Acetylcystein Hexal sometimes smell a bit like sulfur or rotten eggs?

A: Acetylcysteine’s ability to thin mucus comes from its molecular structure, which includes a free sulfhydryl group (SH). This group is chemically related to sulfur compounds and is the source of the medication's characteristic odor.


Q: Can Acetylcystein Hexal be dissolved in drinks other than water?

A: Official administration instructions specify that the effervescent tablet or powder must be fully dissolved in water immediately prior to ingestion. Furthermore, the prepared solution must not be mixed with any other medicinal product.


Q: Does Acetylcystein Hexal interact with levothyroxine for thyroid issues?

A: Official regulatory labels do not specifically list levothyroxine as an interacting drug. However, as a precaution, Acetylcysteine must be separated by at least two hours from the administration of certain oral antibiotics to prevent inactivation. Appropriate timing for any long-term medication is generally confirmed with a healthcare professional.


Q: What's the recommended way to store Acetylcystein Hexal tablets or powder?

A: Official guidance mandates that the medicine must be stored in the original package to ensure protection from moisture. It also has specific temperature constraints, such as being stored at or below 30 C or 25 C depending on the formulation. Regulatory documents state that all medication should be kept out of the sight and reach of children.


Q: Can Acetylcystein Hexal be used for a dry cough or only a wet, chesty cough?

A: The medicine is indicated for thinning abnormally thick, viscous mucus, which is typically associated with a wet, chesty cough. Regulatory guidance also restricts its use alongside cough suppressants (which may be used for dry coughs), as this could lead to the accumulation of secretions.


Q: Is it okay to take Acetylcystein Hexal if I also have high blood pressure?

A: Acetylcysteine is known to potentiate the effect of some vasodilators, like Nitroglycerin, which can cause significant low blood pressure (hypotension). Individuals with high blood pressure should consult with a healthcare professional regarding the use of new medications.


Q: Can Acetylcystein Hexal be used in older adults, and are there specific concerns?

A: The standard adult dosage applies to older adults, and no specific concerns are solely highlighted for this age group in the official documents. However, caution and close supervision are advised for all patients with a history of bronchial asthma or peptic ulcers, conditions which may be more common in older populations.


Q: Is there a link between Acetylcystein Hexal and blood clotting issues?

A: In regulatory safety documentation, very rare adverse reactions such as haemorrhages (bleeding) are documented. It is advisable for individuals with a known bleeding risk to discuss this information with a healthcare professional.


Q: Can Acetylcystein Hexal be used to help with respiratory issues related to smoking?

A: The medication is indicated for respiratory conditions characterized by excessive mucus. Studies have explored its use in chronic conditions like COPD and chronic bronchitis, which are often associated with smoking, due to its potential to reduce the rate of disease exacerbations.


Q: Does Acetylcystein Hexal require a special diet to be effective?

A: Regulatory information directs patients to take the medication, typically after meals. However, no specific or restrictive diet is required for the medicine to be effective.


Q: Is it normal to feel a bit drowsy after taking Acetylcystein Hexal?

A: Drowsiness is not listed as a common side effect for the oral form of the medication. Official reports do document effects on the nervous system, such as headache, and drowsiness has been reported with the use of the inhalation form in specialized contexts.

Advertisements

How should Acetylcystein Hexal be stored and disposed of?

Storage and Protection Requirements

Official labeling mandates specific storage conditions to maintain product integrity and safety.

  • Temperature Constraints: Some formulations, such as effervescent tablets in PP tubes, must be stored at a temperature not above 30 C. Other forms, like certain granules, may require storage not above 25 C.
  • Moisture Protection: The medicine must be stored in the original package to ensure protection from moisture.
  • Child Safety: It is a mandatory requirement to keep this medicine out of the sight and reach of children.

Stability and Disposal Instructions

  • Prepared Solution: The solution created by dissolving the effervescent tablet or sachet contents must be used immediately and must not be stored.
  • Expiry Date: Do not use the medicine after the expiry date shown on the container.
  • Disposal: Unused or expired Acetylcystein Hexal must not be thrown away via wastewater or household waste. Disposal must be carried out by asking a pharmacist for guidance, following all local, regional, and national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acetylcystein Hexal found in:

A-Z Index: